Hydrochloride for Injection, USP in two vial sizes: 25 mg/1 mL and 50 mg/2 mL, further broadening PCC's increasing portfolio ...

School administrators and nurses are encouraged to review applicable state laws and regulations to ensure neffy® (epinephrine ...

"When your commercial content is reaching the market twice as fast as your competition, your new product gets traction." Getting ahead for your first launch success Emerging pharma companies ...

Launching new pharmaceutical products has never been simple, with marketers well aware that a poorly planned and executed initial launch for a new product makes it very hard to be successful in ...

Piramal Pharma said that its subsidiary Piramal Critical Care (PCC) has launched Chlorpromazine Hydrochloride for Injection in various strengths in the US market.

The launch of Chlorpromazine Hydrochloride for Injection, USP (25mg/1mL and 50mg/2 mL vials) is the latest in a series of ...

Aurora announced this week the launch of its brand, IndiMed, which manufactures medical cannabis products at Aurora’s leading ...

Analyst Madison Elsaadi of B.Riley Financial reiterated a Buy rating on Eton Pharmaceuticals (ETON – Research Report), retaining the price ...

The "Pharmaceutical Regulatory Affairs Market Size, Share & Trends Analysis Report By Service Provider, By Service, By ...

ARS Pharmaceuticals (SPRY) announced the launch of the neffyinSchools program. neffyinSchools provides eligible public and private K-12 schools ...

In an interview, the CEO discussed trying to gain support from investors hyper-focused on M&A, and competing with Pfizer and ...